Clinic
Harlingen Medical Center Limited Partnership
Harlingen Medical Center Limited Partnership was paid $4.27M by Medicaid between Jul 2019 and Nov 2024, across 69 billing codes. Its largest line is 99284, emergency room visit (serious) — 35% of everything it billed.
33Billing provider infoHARLINGEN MEDICAL CENTER LIMITED PARTNERSHIP
HARLINGEN, TX 78550
HARLINGEN, TX 78550
33aNPI1881688976assigned 09/06/2005
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$4.27M
24GClaims107,734
24DCodes billed69
24AFirst – last monthJul 2019 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#86 of 320
Median peer was paid$205K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 24 | $117.96 | |
| 2020 | 1,449 | $78K | |
| 2021 | 24,265 | $912K | |
| 2022 | 42,364 | $1.75M | |
| 2023 | 29,333 | $1.19M | |
| 2024incomplete | 10,299 | $342K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 35% | 6,753 | 6,334 | $1.51M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 8,751 | 8,359 | $1.04M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 3,078 | 2,893 | $542K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.1% | 4,828 | 4,647 | $263K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.9% | 8,672 | 4,217 | $209K |
| 80053 | Comprehensive metabolic panel | 2.5% | 9,026 | 8,232 | $105K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.2% | 4,430 | 4,288 | $94K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 10,343 | 9,376 | $83K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 2,487 | 2,345 | $57K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 1,906 | 1,843 | $49K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,708 | 2,551 | $31K |
| G0378 | Hospital observation service, per hour | <1% | 144 | 123 | $31K |
57 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 274 | $29K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,333 | $25K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 534 | $24K |
| 81025 | <1% | 1,999 | $23K | |
| 81001 | <1% | 6,048 | $22K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,257 | $21K |
| 84484 | <1% | 2,026 | $11K | |
| 87088 | <1% | 1,486 | $11K | |
| 83690 | <1% | 1,479 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 290 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,540 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,345 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 791 | $5K |
| 83880 | <1% | 525 | $5K | |
| 80305 | <1% | 410 | $4K | |
| 87807 | <1% | 175 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,222 | $4K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 98 | $4K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 68 | $3K |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 231 | $3K |
| 84702 | <1% | 201 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,072 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 154 | $3K |
| 83605 | <1% | 420 | $2K | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 15 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 13 | $2K |
| CP007 | <1% | 68 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 67 | $2K |
| 82948 | <1% | 1,108 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $2K |
| 76801 | <1% | 15 | $1K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 62 | $1K |
| 82550 | <1% | 616 | $1K | |
| 85730 | <1% | 762 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 996 | $1K |
| 85610 | <1% | 909 | $1K | |
| 81003 | <1% | 620 | $1K | |
| 83735 | <1% | 303 | $1K | |
| 87040 | <1% | 165 | $838.24 | |
| 87186 | <1% | 251 | $717.71 | |
| 86140 | <1% | 146 | $717.34 | |
| 87077 | <1% | 250 | $670.16 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,582 | $311.87 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 18 | $309.24 |
| 96376 | <1% | 18 | $289.35 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 67 | $275.29 |
| 86901 | <1% | 102 | $179.25 | |
| 86900 | <1% | 101 | $176.73 | |
| 84703 | <1% | 24 | $161.84 | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 80 | $79.15 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 21 | $70.94 |
| 84145 | <1% | 13 | $66.30 | |
| 83874 | <1% | 34 | $54.25 | |
| S0028 | Injection, famotidine, 20 mg | <1% | 16 | $50.41 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 13 | $11.05 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 79 | $2.29 |
| 93356 | 0% | 84 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOAN, CHRISTOPHER (MANAGING ASSOCIATE GENERAL COUNSEL)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.